Dear Reader,
Elon Musk made $180 million on PayPal, $18.7 billion on SpaceX, and $110 billion on Tesla.
But it's what he's planning next that will shock everyone.
It could even put up to an extra $30,000 in your pocket every year.
Click here to watch a demo and see it for yourself.
Sincerely,
Van Bryan
Managing Editor, Brownstone Research
Company Overview Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company focused on neuroscience, recently thrust into the spotlight after a major late-stage trial setback.
Daily Financial Update Good Monday morning—let’s cut through the noise and get you up to speed on what really matters. Opening Recap Market Pulse: AI
Overview & Barzolvolimab Breakthrough Celldex Therapeutics (NASDAQ: CLDX) is a clinical-stage biotech focused on immunology, and it recently drew significant attention after unveiling compelling results
